United States Biotechnology & Medical Research

CTT Pharmaceutical Holdings Inc (CTTH)

Track

Track

Over the past ninety days, CTT Pharmaceutical Holdings recorded three insider trading transactions, all representing purchases by the CEO totaling 1202.1 USD. Despite a 38.2% decline in stock value during this period, no selling activity occurred. The company has not released a recent earnings report to provide further context for these acquisitions.
Ticker: CTTH Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for CTT Pharmaceutical Holdings Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Cooper Paul K Chief Operating Officer Officer
Transaction date
Purchase
Price
0.24
Quantity 20,000 +inf%
Value US$4,800
2.0
VAN TOL LARRY President and CEO Executive Director
Transaction date
Purchase
Price
0.30
Quantity 5,000,000 +766.6%
Value US$1,500,000
ROGERS PATRICK E Non-Executive Director
Transaction date
Purchase
Price
0.00
Quantity 100,000
Value US$0
2.0
VAN TOL LARRY President, CEO Executive Director
Transaction date
Purchase
Price
0.95
Quantity 5,000 +0.8%
Value US$4,750
1.2
WEATHERS STEPHEN W
Transaction date
Purchase
Price
2.10
Quantity 380 +1.5%
Value US$798
1.2
WEATHERS STEPHEN W
Transaction date
Purchase
Price
2.10
Quantity 120 +0.5%
Value US$252
1.2
WEATHERS STEPHEN W
Transaction date
Purchase
Price
2.10
Quantity 800 +3.2%
Value US$1,680
2.0
VAN TOL LARRY Non-Executive Director
Transaction date
Purchase
Price
2.80
Quantity 500 +0.1%
Value US$1,400
2.0
VAN TOL LARRY Non-Executive Director
Transaction date
Purchase
Price
2.60
Quantity 2,500 +0.6%
Value US$6,500
2.0
VAN TOL LARRY Non-Executive Director
Transaction date
Purchase
Price
2.55
Quantity 500 +0.1%
Value US$1,275
2.0
VAN TOL LARRY Non-Executive Director
Transaction date
Purchase
Price
3.07
Quantity 500 +0.1%
Value US$1,535
2.0
VAN TOL LARRY
Transaction date
Purchase
Price
3.17
Quantity 2,000 +0.5%
Value US$6,340
2.0
VAN TOL LARRY
Transaction date
Purchase
Price
3.15
Quantity 500 +0.1%
Value US$1,575
1.2
WEATHERS STEPHEN W Non-Executive Director
Transaction date
Purchase
Price
3.15
Quantity 1,000 +6.3%
Value US$3,150
1.2
WEATHERS STEPHEN W Non-Executive Director
Transaction date
Purchase
Price
3.10
Quantity 450 +2.9%
Value US$1,395
WOODHEAD RICHARD H
Transaction date
Sale
Price
3.15
Quantity 1,000 -3.8%
Value US$3,150
WOODHEAD RICHARD H
Transaction date
Sale
Price
3.28
Quantity 2,000 -7.1%
Value US$6,560
WOODHEAD RICHARD H
Transaction date
Sale
Price
3.24
Quantity 2,000 -6.7%
Value US$6,480
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-19 2026-08-19 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
67,662 +2.8%
112.54
US$2,582,946 		67,662 +2.8% 112.54 US$2,582,946
2026-08-14 2026-08-14 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
48,391 -19.6%
385.85
US$4,957,575 		48,391 -19.6% 385.85 US$4,957,575
2026-08-10 2026-08-07 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
20,749 +16.9%
362.50
US$3,081,322 		20,749 +16.9% 362.50 US$3,081,322
2025-12-17 2025-12-17 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
8,300 +0.1%
0.06
US$456 		8,300 +0.1% 0.06 US$456
2025-11-24 2025-11-20 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.
Non-Executive Director
200,000 +5.7%
0.04
US$8,000 		200,000 +5.7% 0.04 US$8,000
2025-11-21 2025-11-20 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
62,900 +0.8%
0.04
US$2,516 		62,900 +0.8% 0.04 US$2,516
2025-10-31 2025-10-31 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
7,000 +0.1%
0.06
US$420 		7,000 +0.1% 0.06 US$420
2025-10-07 2025-09-23 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
6,815 +0.1%
0.06
US$409 		6,815 +0.1% 0.06 US$409
2025-09-23 2025-08-02 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
44,085 +0.6%
0.05
US$1,984 		44,085 +0.6% 0.05 US$1,984
2025-08-01 2025-08-01 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
15,800 +0.2%
0.04
US$553 		15,800 +0.2% 0.04 US$553
2025-07-08 2025-07-08 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
8,000 +0.1%
0.03
US$240 		8,000 +0.1% 0.03 US$240
2025-06-30 2025-06-26 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
39,600 +0.6%
0.03
US$990 		39,600 +0.6% 0.03 US$990
2025-06-23 2025-06-23 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
16,100 +0.2%
0.03
US$402 		16,100 +0.2% 0.03 US$402
2025-06-09 2025-06-09 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
82,158 +1.2%
0.05
US$4,108 		82,158 +1.2% 0.05 US$4,108
2025-04-10 2025-04-09 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
9,984 +0.2%
0.07
US$649 		9,984 +0.2% 0.07 US$649
2025-03-31 2025-03-31 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
15,510 +0.2%
0.05
US$776 		15,510 +0.2% 0.05 US$776
2025-03-14 2025-03-11 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
5,400 +0.1%
0.06
US$324 		5,400 +0.1% 0.06 US$324
2025-03-10 2025-03-07 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
11,950 +0.2%
0.09
US$1,076 		11,950 +0.2% 0.09 US$1,076
2025-02-06 2025-02-05 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
5,200 +0.1%
0.12
US$624 		5,200 +0.1% 0.12 US$624
2024-11-26 2024-11-25 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
23,346 +0.4%
0.06
US$1,401 		23,346 +0.4% 0.06 US$1,401
2024-09-13 2024-09-11 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
750 +0.0%
0.06
US$41 		750 +0.0% 0.06 US$41
2024-09-11 2024-09-11 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
1,100 +0.0%
0.06
US$60 		1,100 +0.0% 0.06 US$60
2024-08-27 2024-08-27 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
550 +0.0%
0.06
US$33 		550 +0.0% 0.06 US$33
2024-08-21 2024-08-19 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
2,900 +0.1%
0.05
US$145 		2,900 +0.1% 0.05 US$145
2024-08-15 2024-08-12 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
1,300 +0.0%
0.04
US$52 		1,300 +0.0% 0.04 US$52
2024-08-09 2024-08-06 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
2,200 +0.0%
0.04
US$92 		2,200 +0.0% 0.04 US$92
2024-08-06 2024-08-05 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
1,000 +0.0%
0.04
US$42 		1,000 +0.0% 0.04 US$42
2024-09-03 2024-08-03 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
1,000 +0.0%
0.06
US$60 		1,000 +0.0% 0.06 US$60
2024-08-02 2024-08-01 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
1,600 +0.0%
0.04
US$64 		1,600 +0.0% 0.04 US$64
2024-07-30 2024-07-26 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
3,100 +0.1%
0.04
US$124 		3,100 +0.1% 0.04 US$124
2024-07-26 2024-07-24 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
1,700 +0.0%
0.04
US$68 		1,700 +0.0% 0.04 US$68
2024-07-24 2024-07-18 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
2,000 +0.0%
0.05
US$100 		2,000 +0.0% 0.05 US$100
2024-07-18 2024-07-16 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
1,800 +0.0%
0.06
US$108 		1,800 +0.0% 0.06 US$108
2024-07-15 2024-07-11 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
1,070 +0.0%
0.06
US$64 		1,070 +0.0% 0.06 US$64
2024-07-11 2024-07-11 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
2,730 +0.1%
0.06
US$164 		2,730 +0.1% 0.06 US$164
2024-07-05 2024-07-05 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
1,454 +0.0%
0.06
US$87 		1,454 +0.0% 0.06 US$87
2024-06-28 2024-06-25 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
1,300 +0.0%
0.06
US$78 		1,300 +0.0% 0.06 US$78
2024-06-24 2024-06-20 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
1,000 +0.0%
0.07
US$70 		1,000 +0.0% 0.07 US$70
2025-06-13 2024-06-13 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
54,798 +0.8%
0.03
US$1,370 		54,798 +0.8% 0.03 US$1,370
2024-06-11 2024-06-11 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
1,990 +0.0%
0.05
US$99 		1,990 +0.0% 0.05 US$99
2024-06-03 2024-06-03 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
7,376 +0.2%
0.02
US$148 		7,376 +0.2% 0.02 US$148
2024-05-22 2024-05-21 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
3,236 +0.1%
0.03
US$84 		3,236 +0.1% 0.03 US$84
2024-05-22 2024-05-21 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
3,236 +0.1%
0.03
US$84 		3,236 +0.1% 0.03 US$84
2024-05-08 2024-05-07 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
9,500 +0.2%
0.04
US$380 		9,500 +0.2% 0.04 US$380
2024-05-08 2024-05-02 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
4,388 +0.1%
0.03
US$136 		4,388 +0.1% 0.03 US$136
2023-03-27 2023-03-27 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
8,700 +1.0%
0.02
US$191 		8,700 +1.0% 0.02 US$191
2023-03-03 2023-03-03 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
3,840 +0.4%
0.04
US$134 		3,840 +0.4% 0.04 US$134
2023-02-08 2023-02-08 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
4,960 +0.6%
0.04
US$174 		4,960 +0.6% 0.04 US$174
2023-01-30 2023-01-30 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
9,000 +1.1%
0.03
US$225 		9,000 +1.1% 0.03 US$225
2023-01-25 2023-01-25 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
61,695 +7.8%
0.02
US$1,481 		61,695 +7.8% 0.02 US$1,481
2023-10-31 2022-08-18 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
500,000 +36.1%
0.02
US$10,000 		500,000 +36.1% 0.02 US$10,000
2023-10-31 2022-02-18 B Purchase
4.4
CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

Officer
500,000 +26.5%
0.02
US$10,000 		500,000 +26.5% 0.02 US$10,000
2007-11-26 2007-11-21 B Purchase Cooper Paul K

Chief Operating Officer

Officer
20,000 +inf%
0.24
US$4,800 		20,000 +inf% 0.24 US$4,800
2006-04-24 2006-04-24 B Purchase
2.0
VAN TOL LARRY

President and CEO

Executive Director
5,000,000 +766.6%
0.30
US$1,500,000 		5,000,000 +766.6% 0.30 US$1,500,000
2005-09-19 2005-09-07 B Purchase
ROGERS PATRICK E
Non-Executive Director
100,000
0.00
US$0 		100,000 0.00 US$0
2005-01-26 2005-01-25 B Purchase
2.0
VAN TOL LARRY

President, CEO

Executive Director
5,000 +0.8%
0.95
US$4,750 		5,000 +0.8% 0.95 US$4,750
2004-10-01 2004-09-30 B Purchase
1.2
WEATHERS STEPHEN W
380 +1.5%
2.10
US$798 		380 +1.5% 2.10 US$798
2004-10-01 2004-09-30 B Purchase
1.2
WEATHERS STEPHEN W
120 +0.5%
2.10
US$252 		120 +0.5% 2.10 US$252
2004-10-01 2004-09-30 B Purchase
1.2
WEATHERS STEPHEN W
800 +3.2%
2.10
US$1,680 		800 +3.2% 2.10 US$1,680
2004-09-17 2004-09-16 B Purchase
2.0
VAN TOL LARRY
Non-Executive Director
500 +0.1%
2.80
US$1,400 		500 +0.1% 2.80 US$1,400
2004-09-17 2004-09-15 B Purchase
2.0
VAN TOL LARRY
Non-Executive Director
2,500 +0.6%
2.60
US$6,500 		2,500 +0.6% 2.60 US$6,500
2004-09-17 2004-09-15 B Purchase
2.0
VAN TOL LARRY
Non-Executive Director
500 +0.1%
2.55
US$1,275 		500 +0.1% 2.55 US$1,275
2004-03-16 2004-03-10 B Purchase
2.0
VAN TOL LARRY
Non-Executive Director
500 +0.1%
3.07
US$1,535 		500 +0.1% 3.07 US$1,535
2004-02-13 2004-02-10 B Purchase
2.0
VAN TOL LARRY
2,000 +0.5%
3.17
US$6,340 		2,000 +0.5% 3.17 US$6,340
2004-02-13 2004-02-10 B Purchase
2.0
VAN TOL LARRY
500 +0.1%
3.15
US$1,575 		500 +0.1% 3.15 US$1,575
2004-01-28 2004-01-28 B Purchase
1.2
WEATHERS STEPHEN W
Non-Executive Director
1,000 +6.3%
3.15
US$3,150 		1,000 +6.3% 3.15 US$3,150
2004-01-16 2004-01-16 B Purchase
1.2
WEATHERS STEPHEN W
Non-Executive Director
450 +2.9%
3.10
US$1,395 		450 +2.9% 3.10 US$1,395
2004-02-02 2004-01-15 S Sale WOODHEAD RICHARD H
1,000 -3.8%
3.15
US$3,150 		1,000 -3.8% 3.15 US$3,150
2004-02-02 2004-01-07 S Sale WOODHEAD RICHARD H
2,000 -7.1%
3.28
US$6,560 		2,000 -7.1% 3.28 US$6,560
2004-02-02 2004-01-06 S Sale WOODHEAD RICHARD H
2,000 -6.7%
3.24
US$6,480 		2,000 -6.7% 3.24 US$6,480
Explore more

More insider trading research around CTT Pharmaceutical Holdings Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America